Subscribe to RSS
DOI: 10.1055/s-2006-931811
© Georg Thieme Verlag Stuttgart · New York
Erektile Dysfunktion
Erectile DysfunctionPublication History
Publication Date:
18 January 2006 (online)
![](https://www.thieme-connect.de/media/psychoneuro/200512/lookinside/thumbnails/10.1055-s-2006-931811-1.jpg)
Zusammenfassung
Sexualstörungen sind in der Diabetologie und anderen medizinischen Fachbereichen unverändert ein vernachlässigtes, häufig tabuisiertes Thema. Es ist bisher nicht in ausreichendem Maße gelungen, klar darzustellen, dass Sexualstörungen, speziell die erektile Dysfunktion, als Folgeschaden z.B. der diabetischen Stoffwechselstörung, einer neurologischen Erkrankung oder eines chronischen Gefäßprozesses anzusehen sind. Neben einer Basisdiagnostik können durch Spezialuntersuchungen Ausmaß und Ursachen einer erektilen Dysfunktion gut erfasst werden. Das vielfältige therapeutische Spektrum ermöglicht heutzutage eine Behandlung bei jeglicher Form der erektilen Dysfunktion.
Summary
Not only in diabetology but also in other medical specialities sexual dysfunction is neglected as it was years ago. Up to now they did not manage to work out that sexual disorders, especially erectile dysfunction are complications of e.g. diabetic metabolism, diverse neurological disorders, or of chronic vascular diseases. Extent and aetiology of erectile dysfunction can be assessed well by some basic diagnostic means completed with special investigations. Today, the variety of therapeutic options allows successful treatment of any type of erectile dysfunction.
Key Words
diabetes mellitus - erectile dysfunction - phosphodiesterase inhibitors
Literatur
- 1 Andersson KE, Wagner G. Physiology of erection. Physiol Rev. 1995; 75 191-236
- 2 Braun M, Wassmer G, Klotz T. et al. . Epidemiology of erectile dysfunction: results of the „Cologne Male Survey”. Int J Impot Res. 2000; 12 305-11
- 3 Brindley GS. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Brit J Psychiat. 1983; 143 332-7
- 4 DePalma RG. Vascular surgery for impotence: a review. Int J Impot Res. 1997; 9 61-8
- 5 Feldman HA, Goldstein I, Hatzichristou D, Krane RJ, McKinlay JB. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol. 1994; 151 54-61
- 6 Giuliano F. Phosphodiesterase type 5 inhibition in erectile dysfunction: an overview. Eur Heart J 2002: H7-H12
- 7 Goldstein I, Young JM, Fischer J, Mollen M. et al. .Vardenafil, a new highly selective PDE5 inhibitor improves erectile function in patients with diabetes mellitus. Proc Am Diabetic Assoc 2001
- 8 Mills RD, Sethia KK. Reproducibility of penile arterial colour duplex ultrasonography. Br J Urol. 1996; 78 109-12
- 9 Musicki B, Kramer MF, Becker RE, Burnett AL. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A. 2005; 102 11870-11875
- 10 Oates CP, Pickard RS, Powell PH, Murthy LNS, Whittingham TAW. Use of duplex ultrasound in assessment of arterial supply to penis in vasculogenic impotence. J Urol. 1995; 153 354-9
- 11 Padma-Nathan H, Wayne JG, Hellstrom WJG. et al. . Treatment of men with erectile dysfunction with transurethral alprostadil. NEJM. 1997; 336 1-7
- 12 Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycaemic control. J Urol. 2000; 163 788-91
- 13 Rosen RC, Riley A, Wagner G, Osterloh H, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for the assessment of erectile dysfunction. Urology. 1997; 49 822-9
- 14 Virag R. Intracavernous injection of papaverine for erectile failure. Lancet. 1982; 2 938
Korrespondenzadresse:
Dr. Volker Müller-Mattheis
Oberarzt d. Urologischen Klinik, Universitätsklinikum d. Heinrich-Heine-Universität Düsseldorf
Moorenstraße 5
40225 Düsseldorf
Email: mattheis@uni-duesseldorf.de